LRRK2 ANTIBODY
|
- $421.6 - $717.4
- Product name: LRRK2 ANTIBODY
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:LRRK2 ANTIBODY
5 prices
Selected condition:
Brand
- Biorbyt Ltd
Package
- 100μg
- 200μg
- ManufacturerBiorbyt Ltd
- Product numberorb150604
- Product descriptionLRRK2 antibody Protein G Purified
- Packaging100μg
- Price$717.4
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb150586
- Product descriptionLRRK2 antibody Protein G Purified
- Packaging100μg
- Price$717.4
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb18949
- Product descriptionLRRK2 antibody Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Packaging100μg
- Price$499.8
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb500678
- Product descriptionLRRK2 antibody Affinity purified by Protein A
- Packaging200μg
- Price$673.2
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb500678
- Product descriptionLRRK2 antibody Affinity purified by Protein A
- Packaging100μg
- Price$421.6
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Biorbyt Ltd | orb150604 | LRRK2 antibody Protein G Purified | 100μg | $717.4 | 2021-12-16 | Buy |
Biorbyt Ltd | orb150586 | LRRK2 antibody Protein G Purified | 100μg | $717.4 | 2021-12-16 | Buy |
Biorbyt Ltd | orb18949 | LRRK2 antibody Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. | 100μg | $499.8 | 2021-12-16 | Buy |
Biorbyt Ltd | orb500678 | LRRK2 antibody Affinity purified by Protein A | 200μg | $673.2 | 2021-12-16 | Buy |
Biorbyt Ltd | orb500678 | LRRK2 antibody Affinity purified by Protein A | 100μg | $421.6 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|